0001903359-23-000001.txt : 20230106 0001903359-23-000001.hdr.sgml : 20230106 20230106160626 ACCESSION NUMBER: 0001903359-23-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20230106 DATE AS OF CHANGE: 20230106 EFFECTIVENESS DATE: 20230106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Wellington Biomedical Innovation Investors (Cayman) II L.P. CENTRAL INDEX KEY: 0001903359 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-428447 FILM NUMBER: 23515121 BUSINESS ADDRESS: STREET 1: 280 CONGRESS STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-951-5000 MAIL ADDRESS: STREET 1: 280 CONGRESS STREET CITY: BOSTON STATE: MA ZIP: 02210 D/A 1 primary_doc.xml X0708 D/A LIVE 0001903359 Wellington Biomedical Innovation Investors (Cayman) II L.P. 280 CONGRESS STREET BOSTON MA MASSACHUSETTS 02210 617-951-5000 CAYMAN ISLANDS None None Other CAYMAN ISLANDS EXEMPTED LIMITED PARTNERSHIP true 2021 N/A WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA MASSACHUSETTS 02210 Executive Officer Promoter GENERAL PARTNER N/A WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA MASSACHUSETTS 02210 Executive Officer Promoter INVESTMENT MANAGER N/A WELLINGTON MANAGEMENT INVESTMENT, INC. 280 CONGRESS STREET BOSTON MA MASSACHUSETTS 02210 Executive Officer MANAGING MEMBER OF THE GENERAL PARTNER Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.7 true 0001903359-22-000001 2022-01-10 true true false 0 WELLINGTON FUNDS DISTRIBUTORS INC. 152768 None None 280 CONGRESS STREET BOSTON MA MASSACHUSETTS 02210 All States false GOLDMAN SACHS & CO. LLC 361 None None 200 WEST STREET NEW YORK NY NEW YORK 10282-2198 All States false J.P. MORGAN SECURITIES LLC 79 None None 390 MADISON AVENUE NEW YORK NY NEW YORK 10017 All States false Indefinite 192515000 Indefinite false 24 0 0 THE MANAGEMENT COMPANY OR ITS AFFILIATE IS REQUIRED TO PAY PLACEMENT FEES BASED ON THE AGGREGATE CAPITAL COMMITMENTS OF CERTAIN INVESTORS IN THE FUND. 0 false Wellington Biomedical Innovation Investors (Cayman) II L.P. MEREDITH MORAN MEREDITH MORAN VICE PRESIDENT 2023-01-06